Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07248540

IV Magnesium in the Treatment of Acute Dysmenorrhea

Evaluation of Intravenous Magnesium Administration in the Treatment of Dysmenorrhea

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Havva Betül Bacak · Other Government
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Not accepted

Summary

This prospective, randomized, double-blind clinical trial aims to evaluate the analgesic efficacy of intravenous magnesium sulfate in women presenting to the emergency department with acute dysmenorrhea. Participants will be randomized into two groups receiving either 2 ampoules of magnesium sulfate or intravenous dexketoprofen. Pain levels will be assessed using the Visual Analog Scale (VAS) before and after treatment.

Detailed description

This prospective, randomized, double-blind clinical trial is designed to evaluate the analgesic effectiveness of intravenous magnesium sulfate in women aged 18 to 35 years presenting to the emergency department with acute dysmenorrhea. Participants will be randomly assigned to one of two treatment groups: 2 ampoules of magnesium sulfate or intravenous dexketoprofen. All medications will be diluted in 100 ml of normal saline and administered intravenously over 15 minutes. Pain intensity will be assessed using the Visual Analog Scale (VAS) before treatment and 1 hour after administration. Secondary outcomes include patient satisfaction, vital sign changes, and adverse effects. The study aims to compare the analgesic efficacy and safety profile of intravenous magnesium sulfate with that of a standard nonsteroidal anti-inflammatory drug (dexketoprofen) in the management of acute dysmenorrhea.

Conditions

Interventions

TypeNameDescription
DRUGMagnesium Sulfate (2 Ampoules)Intravenous administration of 2 ampoules (8 ml total) of magnesium sulfate diluted in 100 ml normal saline, infused over 15 minutes.
DRUGDexketoprofenIntravenous administration of 50 mg dexketoprofen diluted in 100 ml normal saline, infused over 15 minutes.

Timeline

Start date
2025-07-01
Primary completion
2026-01-01
Completion
2026-01-01
First posted
2025-11-25
Last updated
2025-11-25

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07248540. Inclusion in this directory is not an endorsement.